White Matter Plasticity in Schizophrenia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

White Matter Plasticity in Schizophrenia — Stella

Home/Schizophrenia Disorders/

View on ClinicalTrials.gov

Recruiting

Back to Schizophrenia Disorders trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Maryland Psychiatric Research Center, Catonsville, Maryland

University of Maryland Baltimore - Maryland Psychiatric Research Center, Catonsville, Maryland

Key details

Sponsor

University of Maryland, Baltimore

Enrollment target

~36 participants

Started

January 2025

Primary completion

December 2026

Age range

15 Years – 45 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.